BRPI0814304A8 - Uso de um composto metálico misto - Google Patents
Uso de um composto metálico mistoInfo
- Publication number
- BRPI0814304A8 BRPI0814304A8 BRPI0814304A BRPI0814304A BRPI0814304A8 BR PI0814304 A8 BRPI0814304 A8 BR PI0814304A8 BR PI0814304 A BRPI0814304 A BR PI0814304A BR PI0814304 A BRPI0814304 A BR PI0814304A BR PI0814304 A8 BRPI0814304 A8 BR PI0814304A8
- Authority
- BR
- Brazil
- Prior art keywords
- metallic compound
- weight
- mixed metallic
- granular material
- mixed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
USO DE UM COMPOSTO METÁLICO MISTO. É apresentado o uso de um composto metálico misto na fabricação de medicamentos para a neutralização ou tamponamento da acidez do estômago, onde o composto metálico misto contém pelo menos um metal trivalente escolhido de ferro (III) e alumínio e pelo menos um metal divalente, escolhido de magnésio, ferro, zinco, cálcio, lantânio e cério, onde (A) o composto metálico misto tem a fórmula (I): m ,MIII,ObA"",zll2O (I) onde M11 é pelo menos um metal bivalente; Miii é pelo menos um metal trivalente; A"" é pelo menos um ânion n-valente; 2 + a = 2b + Ecn e Ecn < 0,9a, e z é 2 ou menos, e/ou (B) o composto metálico misto é fomecido na forma de um material granular constituído de (i) pelo menos 5Õ°/o em peso, com base no peso do material granular, do composto metálico misto (ii) 3 a 1 2°/, em peso, com base no peso do material granular, de água não quimicamente ligada, e (iii) não mais do que 47% em peso, com base no peso do material granular, de excipiente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0714670.7A GB0714670D0 (en) | 2007-07-27 | 2007-07-27 | Use |
PCT/GB2008/002533 WO2009016349A1 (en) | 2007-07-27 | 2008-07-24 | Mixed metal compounds used as antacids |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0814304A2 BRPI0814304A2 (pt) | 2015-02-03 |
BRPI0814304A8 true BRPI0814304A8 (pt) | 2016-01-19 |
Family
ID=38512977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0814304A BRPI0814304A8 (pt) | 2007-07-27 | 2008-07-24 | Uso de um composto metálico misto |
Country Status (11)
Country | Link |
---|---|
US (1) | US10201501B2 (pt) |
EP (2) | EP2194972B1 (pt) |
JP (3) | JP5762742B2 (pt) |
KR (2) | KR101653690B1 (pt) |
CN (1) | CN101754751B (pt) |
BR (1) | BRPI0814304A8 (pt) |
ES (1) | ES2627729T3 (pt) |
GB (1) | GB0714670D0 (pt) |
HK (1) | HK1243321A1 (pt) |
RU (2) | RU2596489C2 (pt) |
WO (1) | WO2009016349A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
GB0714670D0 (en) | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
GB0913525D0 (en) * | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
JP5910907B2 (ja) * | 2010-02-19 | 2016-04-27 | 株式会社海水化学研究所 | 胃潰瘍治療剤 |
JP5167389B2 (ja) * | 2010-07-07 | 2013-03-21 | 日本たばこ産業株式会社 | クエン酸第二鉄を含む錠剤 |
AP4068A (en) | 2012-03-02 | 2017-03-15 | Council Scient Ind Res | Double fortified salt composition containing iron and iodine and process for the preparation thereof |
US11851350B1 (en) * | 2017-10-25 | 2023-12-26 | National Technology & Engineering Solutions Of Sandia, Llc | Double charge composite materials for contaminant removal and methods of making the same |
RU2678007C1 (ru) * | 2017-12-05 | 2019-01-22 | Федеральное государственное бюджетное учреждение науки Федеральный исследовательский центр "Кольский научный центр Российской академии наук" (ФИЦ КНЦ РАН) | Способ получения слоистого гидроксида магния и алюминия |
AU2019363816A1 (en) | 2018-10-25 | 2021-05-13 | Eirgen Pharma Ltd. | Methods of treatment with mixed metal compounds |
CN109459543A (zh) * | 2018-12-21 | 2019-03-12 | 马德君 | 一种测试含镁无机抗酸剂体外抗酸性能的方法 |
RU2758671C1 (ru) * | 2020-12-08 | 2021-11-01 | Федеральное государственное бюджетное учреждение науки Институт физики прочности и материаловедения Сибирского отделения Российской академии наук (ИФПМ СО РАН) | СПОСОБ ПОЛУЧЕНИЯ НАНОСТРУКТУРНЫХ ДВОЙНЫХ ГИДРОКСИДОВ НА ОСНОВЕ АЛЮМИНИЯ И ЩЕЛОЧНОЗЕМЕЛЬНЫХ МЕТАЛЛОВ, ТАКИХ КАК МАГНИЙ ИЛИ КАЛЬЦИЙ, ОБЛАДАЮЩИХ СВОЙСТВОМ ПОВЫШАТЬ pH КЛЕТОЧНОЙ СРЕДЫ, И НАНОСТРУКТУРЫ, ПОЛУЧЕННЫЕ ДАННЫМ СПОСОБОМ |
Family Cites Families (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2222924A (en) * | 1936-12-10 | 1940-11-26 | Degussa | Preparation of cerium sulphate |
US2812344A (en) * | 1956-02-13 | 1957-11-05 | Ortho Pharma Corp | Ferrous calcium citrate complex |
FR1214473A (fr) | 1959-01-07 | 1960-04-08 | Procédé de préparation d'un catalyseur à base d'hydroxyde de cérium | |
BE590192A (pt) * | 1959-04-27 | |||
US3395211A (en) * | 1965-12-10 | 1968-07-30 | Carter Wallace | Tableting process |
US3539306A (en) | 1966-07-25 | 1970-11-10 | Kyowa Chem Ind Co Ltd | Process for the preparation of hydrotalcite |
US3796792A (en) * | 1969-12-12 | 1974-03-12 | Kyowa Chem Ind Co Ltd | Composite metal hydroxides |
SU414849A1 (ru) | 1971-05-21 | 1977-09-05 | Харьковский домостроительный комбинат | Бетонна смесь |
BE792032A (fr) | 1971-12-23 | 1973-03-16 | Baxter Laboratories Inc | Dispositif de transfert de masse ayant une membrame semi-permeable disposee en spirale et presentant un faible volume de fluide |
NL174720C (nl) | 1973-12-13 | 1984-08-01 | Philips Nv | Beeldweergeefcel en methode voor de vervaardiging van een vloeibaar kristallijn p-n.butyl-p'-alkoxyazobenzeen. |
FR2435442A1 (fr) | 1978-09-07 | 1980-04-04 | Om Lab Sa | Silicate de magnesium et d'aluminium synthetique, procede de fabrication de celui-ci et compositions pharmaceutiques comprenant celui-ci |
US4192900A (en) * | 1978-10-12 | 1980-03-11 | Merck & Co., Inc. | Texturized starch products |
DE2845326C2 (de) * | 1978-10-18 | 1985-05-23 | Beiersdorf Ag, 2000 Hamburg | Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung |
DE3039997A1 (de) * | 1980-10-23 | 1982-06-03 | Bayer Ag, 5090 Leverkusen | Phosphonohydroxyacetonitril, ein verfahren zu seiner herstellung und seine verwendung als zwischenprodukt fuer die herstellung von arzneimitteln |
US4351814A (en) * | 1980-12-18 | 1982-09-28 | Kyowa Chemical Industry Co., Ltd. | Hydrotalcites having a hexagonal needle-like crystal structure and process for production thereof |
JPS57156419A (en) * | 1981-03-24 | 1982-09-27 | Kyowa Chem Ind Co Ltd | Remedy for sideropenia |
US4514389A (en) * | 1981-05-06 | 1985-04-30 | Kyowa Chemical Industry Co. Ltd. | Gastric antacid and method for controlling pH of gastric juice |
CA1198674A (en) | 1981-11-23 | 1985-12-31 | Rorer International (Holdings) Inc. | Antacid compositions |
US4458026A (en) * | 1982-06-02 | 1984-07-03 | Union Carbide Corporation | Catalysts for aldol condensations |
US4582705A (en) * | 1982-07-12 | 1986-04-15 | Leonard Primes | Composition for detoxification |
JPS606619A (ja) * | 1983-06-27 | 1985-01-14 | Kyowa Chem Ind Co Ltd | 鉄分欠乏症処置剤及びその製法 |
GB8317595D0 (en) * | 1983-06-29 | 1983-08-03 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
US4609543A (en) * | 1983-11-14 | 1986-09-02 | Nabisco Brands, Inc. | Soft homogeneous antacid tablet |
JPS60131604A (ja) | 1983-12-20 | 1985-07-13 | Victor Co Of Japan Ltd | 磁気記録再生素子 |
DE3346943A1 (de) | 1983-12-24 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | Herstellung von hydrotalcit mit verbesserten eigenschaften |
DE3402878A1 (de) | 1984-01-27 | 1985-08-01 | Algina AG, Zug | Arzneimittel und die verwendung schwerloeslicher calcium- und/oder magnesiumverbindungen als arzneimittel |
FR2559755A1 (fr) * | 1984-02-20 | 1985-08-23 | Rhone Poulenc Spec Chim | Oxyde cerique a nouvelles caracteristiques morphologiques et son procede d'obtention |
JPS6136222A (ja) | 1984-07-26 | 1986-02-20 | Chugai Pharmaceut Co Ltd | 高リン酸血症治療剤 |
US4566986A (en) * | 1984-08-31 | 1986-01-28 | Waldmann John J | Flocculating agents and processes for making them |
DE3520108A1 (de) * | 1985-06-05 | 1986-12-11 | Varta Batterie Ag, 3000 Hannover | Positive sammlerelektrode fuer akkumulatoren mit alkalischem elektrolyten |
JPH06705B2 (ja) | 1985-12-19 | 1994-01-05 | 旭化成工業株式会社 | リン酸イオンの固定化剤 |
US6749864B2 (en) * | 1986-02-13 | 2004-06-15 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
US4871392A (en) | 1986-05-23 | 1989-10-03 | American Cyanamid Company | Aqueous suspension concentrate compositions of pendimethalin |
US4801454A (en) * | 1986-07-17 | 1989-01-31 | The Proctor & Gamble Company | Processes for making colored pharmaceutical compositions |
DE3864932D1 (de) * | 1987-06-29 | 1991-10-24 | Rhone Poulenc Chimie | Verfahren zur gewinnung eines ceriumoxids. |
US4994283A (en) * | 1987-07-02 | 1991-02-19 | The Procter & Gamble Company | Iron-calcium mineral supplements with enhanced bioavailability |
US4786510A (en) * | 1987-07-02 | 1988-11-22 | The Procter & Gamble Company | Calcium-iron mineral supplements |
DE3801382A1 (de) | 1988-01-19 | 1989-08-03 | Ebner Anlagen & Apparate | Verfahren und anlage zur umwandlung von natriumsulfat in natriumhydroxid |
EP0330284B1 (en) * | 1988-02-25 | 1994-07-27 | Yamanouchi Europe B.V. | Process for the preparation of a pharmaceutical granulate |
HU201880B (en) | 1988-06-21 | 1991-01-28 | Semmelweis Orvostudomanyi Egye | Process for producing pharmaceutical compositions for profilacting and treating renal diseases and for diminishing frequency of extracorporalis dialysis |
GB8826333D0 (en) | 1988-11-10 | 1988-12-14 | Unilever Plc | Oral compositions |
US5153156A (en) * | 1989-04-18 | 1992-10-06 | Aristech Chemical Corporation | Process for making efficient anionic clay catalyst, catalysts made thereby, and method of making isophorone |
FR2647433B1 (fr) * | 1989-05-23 | 1991-10-31 | Lafarge Coppee Da | Procede de preparation par voie aqueuse de sulfate de calcium purifie |
US4970079A (en) | 1989-06-05 | 1990-11-13 | Purdue Research Foundation | Method and composition of oxy-iron compounds for treatment of hyperphosphatemia |
US5112604A (en) * | 1989-09-01 | 1992-05-12 | Riker Laboratories, Inc. | Oral suspension formulation |
ES2018952A6 (es) | 1989-10-17 | 1991-05-16 | Walton Sa | Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica. |
JP2918619B2 (ja) * | 1990-04-06 | 1999-07-12 | 花王株式会社 | 金属磁性粉末の製造方法及び磁気記録媒体用塗膜 |
CA2082639A1 (en) | 1990-06-08 | 1991-12-09 | Terence William Turney | Ethylene sorbing substances |
US5300302A (en) * | 1990-10-04 | 1994-04-05 | Nestec S.A. | Pharmaceutical composition in gel form in a dispensing package |
DE4036757A1 (de) * | 1990-11-17 | 1992-05-21 | Bayer Ag | Antazida-zubereitung mit verlaengerter magenverweilzeit |
GB2253164B (en) * | 1991-02-22 | 1994-10-05 | Hoechst Uk Ltd | Improvements in or relating to electrostatic coating of substrates of medicinal products |
GB2254556B (en) | 1991-04-11 | 1995-04-12 | Fisons Plc | Formulations containing linolenic acid |
US5246899A (en) * | 1991-08-16 | 1993-09-21 | Amoco Corporation | Simplified preparation of hydrotalcite-type clays |
JPH05105636A (ja) * | 1991-10-14 | 1993-04-27 | Lion Corp | 制酸剤組成物 |
JPH05155776A (ja) | 1991-12-02 | 1993-06-22 | Otsuka Pharmaceut Factory Inc | 高リン血症治療剤 |
JPH05208816A (ja) | 1992-01-28 | 1993-08-20 | Sumitomo Metal Mining Co Ltd | 水酸化セリウム及び酸化セリウムの製造方法 |
WO1993022237A1 (en) | 1992-04-30 | 1993-11-11 | J.M. Huber Corporation | Method for production of synthetic hydrotalcite |
US5380542A (en) | 1992-06-19 | 1995-01-10 | Rhone-Poulenc Specialties Chemical Co. | Dietary fiber compositions for use in foods |
JP3454845B2 (ja) | 1992-07-15 | 2003-10-06 | 株式会社東芝 | 閉鎖配電盤 |
US5273767A (en) * | 1992-09-09 | 1993-12-28 | Merck & Co., Inc. | Rapidly hydrating gums |
JPH08502976A (ja) | 1992-10-29 | 1996-04-02 | シー−ピー テクノロジー リミテッド パートナーシップ | カルシウムおよび硫酸塩を含有した組成物および複合体、その合成法、これを用いた治療法、これを含んでなる化粧用調製物 |
NL9201907A (nl) * | 1992-11-02 | 1994-06-01 | Tno | Peristaltisch mengende reactor en peristaltische kleppenpomp. |
DE4239442C2 (de) * | 1992-11-24 | 2001-09-13 | Sebo Gmbh | Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten |
CA2110313C (en) * | 1992-12-01 | 2004-10-26 | Edward John Roche | Pharmaceutical compositions containing a guanidinothiazole compound and antacids |
US5506248A (en) * | 1993-08-02 | 1996-04-09 | Bristol-Myers Squibb Company | Pharmaceutical compositions having good dissolution properties |
TW397686B (en) | 1993-08-11 | 2000-07-11 | Takeda Chemical Industries Ltd | Antacid compositions and pharmaceutical compositions |
WO1995011033A1 (en) | 1993-10-22 | 1995-04-27 | Commonwealth Scientific And Industrial Research Organisation | Polyoxometallates in the treatment of flavivirus infections |
TW390813B (en) | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
BR9508844A (pt) | 1994-09-21 | 1999-05-04 | Unilever Nv | Composição oral |
GB9506126D0 (en) * | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
EP0854916A4 (en) | 1995-09-20 | 2002-07-24 | Univ Queensland | NEW ACC SYNTHASE GENES |
US5571336A (en) * | 1995-09-29 | 1996-11-05 | Wurzburger; Stephen R. | Base solution for cleaning aluminum |
DE19547356A1 (de) * | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung |
NZ325747A (en) | 1996-01-25 | 1999-01-28 | Colin Leslie Young | Stomach-action molluscicides |
SE9602442D0 (sv) | 1996-06-20 | 1996-06-20 | Astra Ab | Administration of pharmaceuticals |
DK0922464T3 (da) * | 1996-07-12 | 2005-06-06 | Daiichi Seiyaku Co | Hurtigt desintegrerbare, kompressionsstöbte materialer og fremgangsmåder til fremstilling af samme |
US5654011A (en) * | 1996-07-30 | 1997-08-05 | Energetics, Inc. | Dietary supplements |
JPH1059842A (ja) | 1996-08-13 | 1998-03-03 | Lion Corp | 錠剤用組成物及び打錠方法 |
JPH10101569A (ja) * | 1996-10-01 | 1998-04-21 | Eisai Co Ltd | 制酸剤 |
JPH10236960A (ja) | 1997-02-24 | 1998-09-08 | Lion Corp | 制酸剤含有組成物 |
TW592727B (en) * | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
GB9720061D0 (en) * | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
US6028023A (en) * | 1997-10-20 | 2000-02-22 | Bulldog Technologies U.S.A., Inc. | Process for making, and use of, anionic clay materials |
AU741992B2 (en) | 1998-03-06 | 2001-12-13 | Adare Pharmaceuticals S.R.L. | Fast disintegrating tablets |
JPH11335269A (ja) * | 1998-05-19 | 1999-12-07 | Hisamitsu Pharmaceut Co Inc | 遺伝子関連医薬の経口投与固形製剤 |
JP2000086537A (ja) | 1998-09-11 | 2000-03-28 | Fuji Chem Ind Co Ltd | 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法 |
SA99191255B1 (ar) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
KR100331529B1 (ko) * | 1999-06-16 | 2002-04-06 | 민경윤 | 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법 |
US6448323B1 (en) * | 1999-07-09 | 2002-09-10 | Bpsi Holdings, Inc. | Film coatings and film coating compositions based on polyvinyl alcohol |
US6177581B1 (en) | 1999-10-12 | 2001-01-23 | The Dow Chemical Company | Mixed-metal chelates and process for the preparation thereof |
US6733780B1 (en) * | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
DE19958007A1 (de) * | 1999-12-02 | 2001-06-07 | Roehm Gmbh | Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen |
WO2001049302A1 (en) | 2000-01-06 | 2001-07-12 | Marantech Holding, Llc | Compositions and methods for facilitating skin growth and managing skin conditions |
AUPQ533700A0 (en) * | 2000-01-28 | 2000-02-17 | Commonwealth Scientific And Industrial Research Organisation | Soil treatment method |
US20030185886A1 (en) * | 2000-05-26 | 2003-10-02 | Hanmi Pharm. Co., Ltd. | Process for the preparation of rapidly disintegrating tablet |
FR2809407B1 (fr) * | 2000-05-26 | 2002-08-30 | Rhodia Chimie Sa | Utilisation d'hydrotalcite comme charge dans des compositions de polymeres |
US6720005B1 (en) * | 2000-07-07 | 2004-04-13 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Coated, platform-generating tablet |
IN192168B (pt) | 2000-11-24 | 2004-03-06 | Council Scient Ind Res | |
US6576665B2 (en) * | 2001-04-03 | 2003-06-10 | Braintree Laboratories, Inc. | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
AU2002346065A1 (en) * | 2001-07-05 | 2003-01-21 | Marantech Holding, Llc | Methods of using electron active compounds for managing conditions afflicting mammals |
UA80682C2 (en) | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
ES2296960T3 (es) * | 2001-08-27 | 2008-05-01 | Kyowa Chemical Industry Co., Ltd. | Comprimido antiacido y laxante que contiene oxido de magnesio. |
AR036354A1 (es) | 2001-08-31 | 2004-09-01 | Takeda Chemical Industries Ltd | Preparacion solida |
KR20040037138A (ko) | 2001-09-28 | 2004-05-04 | 가부시키가이샤산와카가쿠켄큐쇼 | 유핵형 속용붕괴성 성형품 |
GB0204771D0 (en) | 2002-02-28 | 2002-04-17 | Phoqus Ltd | Fast disintegrating tablets |
US7300670B2 (en) * | 2002-04-03 | 2007-11-27 | Unilab Pharmatech, Ltd. | Oral suspension formulation |
ATE329582T1 (de) | 2002-04-29 | 2006-07-15 | Egyt Gyogyszervegyeszeti Gyar | Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit |
US20040161474A1 (en) | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
CN1970680B (zh) * | 2002-06-25 | 2015-08-26 | 罗狄亚公司 | 油井压裂剂 |
CN1326612C (zh) | 2002-08-09 | 2007-07-18 | 阿尔伯麦尔荷兰有限公司 | 使用含铁层状材料的费-托法 |
JP4348426B2 (ja) | 2002-08-29 | 2009-10-21 | 独立行政法人産業技術総合研究所 | 高選択性脱リン剤及びその製造方法 |
US20040226620A1 (en) * | 2002-09-26 | 2004-11-18 | Daniel Therriault | Microcapillary networks |
CA2513469C (en) * | 2003-01-28 | 2016-05-17 | The University Of Wyoming Research Corporation D/B/A/ Western Research Institute | Bioagent air filtration systems |
AR045068A1 (es) | 2003-07-23 | 2005-10-12 | Univ Missouri | Formulacion de liberacion inmediata de composiciones farmaceuticas |
US7381428B2 (en) * | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
CZ17621U1 (cs) | 2003-08-26 | 2007-06-25 | Shire Holdings Ag | Farmaceutický prostredek zahrnující slouceniny lanthanu |
WO2005027876A1 (en) | 2003-08-28 | 2005-03-31 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of benzimidazole and processes for their preparation |
BE1015841A3 (fr) * | 2003-12-24 | 2005-10-04 | Lhoist Rech & Dev Sa | Composition pulverulente a base d'un compose calco-magnesien. |
US20050260271A1 (en) * | 2004-05-20 | 2005-11-24 | Eastman Kodak Company | Composition comprising layered host material with intercalated functional-active organic compound |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20060177415A1 (en) * | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
GB0502787D0 (en) * | 2005-02-10 | 2005-03-16 | Ineos Silicas Ltd | Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use |
JP4823547B2 (ja) | 2005-03-28 | 2011-11-24 | 株式会社ジーシー | ペースト状歯科用アルギン酸塩印象材組成物 |
CN101389316A (zh) * | 2005-12-28 | 2009-03-18 | 武田药品工业株式会社 | 控制释放固体制剂 |
MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
AU2007253083B2 (en) | 2006-05-19 | 2012-07-19 | Norbrook Laboratories Limited | Stable aqueous suspension having palatable taste |
EP2918548A1 (en) | 2006-12-14 | 2015-09-16 | Novartis Tiergesundheit AG | Iron(iii) sugar based phosphate adsorbent |
PT2319804E (pt) | 2006-12-14 | 2014-11-24 | Novartis Ag | Adsorvente de fosfato à base de ferro (iii)-carboidrato |
EP1946750A1 (en) | 2007-01-18 | 2008-07-23 | The Jordanian Pharmaceutical Manufacturing Co. | Co-precipitate, method for preparing the same and uses thereof |
WO2008129034A1 (en) | 2007-04-20 | 2008-10-30 | Euro Support Catalyst Group Bv | Hydrotalcite-like layered double hydroxide (ldh) composition and process of making same |
GB0714670D0 (en) | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) * | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
GB0913525D0 (en) * | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
GB201001779D0 (en) * | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
-
2007
- 2007-07-27 GB GBGB0714670.7A patent/GB0714670D0/en not_active Ceased
-
2008
- 2008-07-24 US US12/670,834 patent/US10201501B2/en not_active Expired - Fee Related
- 2008-07-24 BR BRPI0814304A patent/BRPI0814304A8/pt not_active IP Right Cessation
- 2008-07-24 EP EP08776045.0A patent/EP2194972B1/en active Active
- 2008-07-24 EP EP17159665.3A patent/EP3210600B1/en not_active Not-in-force
- 2008-07-24 ES ES08776045.0T patent/ES2627729T3/es active Active
- 2008-07-24 RU RU2013151299/15A patent/RU2596489C2/ru not_active IP Right Cessation
- 2008-07-24 CN CN2008800254937A patent/CN101754751B/zh not_active Expired - Fee Related
- 2008-07-24 RU RU2010106856/15A patent/RU2510265C2/ru not_active IP Right Cessation
- 2008-07-24 JP JP2010517482A patent/JP5762742B2/ja not_active Expired - Fee Related
- 2008-07-24 KR KR1020107001670A patent/KR101653690B1/ko active IP Right Grant
- 2008-07-24 KR KR1020157003291A patent/KR101653691B1/ko active IP Right Grant
- 2008-07-24 WO PCT/GB2008/002533 patent/WO2009016349A1/en active Application Filing
-
2010
- 2010-09-17 HK HK18102642.8A patent/HK1243321A1/zh unknown
-
2014
- 2014-12-19 JP JP2014257980A patent/JP6148223B2/ja not_active Expired - Fee Related
-
2017
- 2017-02-28 JP JP2017036627A patent/JP6466980B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2194972B1 (en) | 2017-03-08 |
KR101653691B1 (ko) | 2016-09-02 |
JP6148223B2 (ja) | 2017-06-14 |
JP2017132778A (ja) | 2017-08-03 |
CN101754751A (zh) | 2010-06-23 |
KR20100035167A (ko) | 2010-04-02 |
KR101653690B1 (ko) | 2016-09-02 |
US20100203152A1 (en) | 2010-08-12 |
CN101754751B (zh) | 2013-03-06 |
JP5762742B2 (ja) | 2015-08-12 |
JP2010534643A (ja) | 2010-11-11 |
BRPI0814304A2 (pt) | 2015-02-03 |
JP2015096538A (ja) | 2015-05-21 |
RU2596489C2 (ru) | 2016-09-10 |
ES2627729T3 (es) | 2017-07-31 |
WO2009016349A1 (en) | 2009-02-05 |
US10201501B2 (en) | 2019-02-12 |
GB0714670D0 (en) | 2007-09-05 |
EP3210600A1 (en) | 2017-08-30 |
RU2510265C2 (ru) | 2014-03-27 |
HK1243321A1 (zh) | 2018-07-13 |
JP6466980B2 (ja) | 2019-02-06 |
KR20150034245A (ko) | 2015-04-02 |
EP2194972A1 (en) | 2010-06-16 |
EP3210600B1 (en) | 2019-03-27 |
RU2013151299A (ru) | 2015-05-27 |
RU2010106856A (ru) | 2011-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0814304A8 (pt) | Uso de um composto metálico misto | |
CR20150031A (es) | Material | |
BR112015014445A2 (pt) | complexo de zinco-lisina | |
UA107195C2 (uk) | Добавки для гідравлічного в'яжучого матеріалу на основі клінкеру з беліту і сульфоалюмінату-фериту кальцію | |
BR112012024783A2 (pt) | composição de combustível diesel à base de éter dietílico | |
AR111146A2 (es) | Compuesto de metal mixto y composición farmacéutica que lo comprende | |
BR112015002312A2 (pt) | chapa de aço laminada a frio e método para produção da mesma, e elememento conformado por estampagem a quente | |
BR112013028921A2 (pt) | catalisador com um aglutinante modificado por íon | |
CL2008001118A1 (es) | Composicion de tratamiento de agua granular que comprende 35 a 95% en peso de hipoclorito de calcio, 1 a 50% de sulfato de magnesio, 0,1 a 10% de cal y 0,1 a 55% de sal de zinc soluble en agua; comprimido para el tratamiento de agua; y metodo para el | |
BR112013009034A2 (pt) | composições de revestimento com propriedades anticorrosão | |
MX2009008205A (es) | Composiciones de bebida que comprenden polilisina y por lo menos un acido debil. | |
PE20060364A1 (es) | Forma cristalina alfa del ranelato de estroncio, procedimiento para su preparacion y composiciones farmaceuticas que la contienen | |
JP2010534643A5 (pt) | ||
WO2014096372A3 (de) | Zusammensetzung einer magnesiumsulfat-harnstoff-verbindung | |
DE502007004325D1 (de) | Salzersatzmischung mit vermindertem nacl-gehalt | |
WO2008090870A1 (ja) | 芳香族ポリエステル系樹脂成形体およびその製造方法 | |
BRPI0708278B8 (pt) | forma cristalina "a" do sal de arginina de perindopril, seu uso, processo para sua preparação e composição farmacêutica | |
TW200640476A (en) | Pharmaceutically active compounds, their manufacture, compositions containing them and their use | |
CA2581265A1 (en) | Calcium hypochlorite composition | |
MY148407A (en) | Zinc-containing calcium-aluminium double salts | |
MY171380A (en) | Rapid hydraulic binder comprising a calcium salt | |
BR112015008439A2 (pt) | método para evitar crescimento fúngico em materiais de construção mineral | |
JP2014122129A5 (pt) | ||
BR112015008372A2 (pt) | uso de uma composição de lldpe em aplicações de cuidados de saúde | |
BR112012021744A2 (pt) | composição de de doença de planta e método para controlar doença de planta. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: CYTOCHROMA DEVELOPMENT INC. (BB) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2467 DE 17/04/2018 POR TER SIDO INDEVIDA. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2594 DE 24-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |